据 Insight 数据库统计，本周（8 月 3 日—8 月 9 日）全球共有 105 款创新药（含改良新）研发进度推进到了新阶段，其中 1 款获批上市，3 款申报上市，33 款启动临床，12 款申报临床。下文，Insight 将分别摘取本周国内外部分重点项目进展做介绍。境外创新药进展境外部分，本周共有 37 款药物研发阶段推进，包括 2 款获批上市，2 款申报上市，2 款首次启动 III 期临床...
Source Link据 Insight 数据库统计，本周（8 月 3 日—8 月 9 日）全球共有 105 款创新药（含改良新）研发进度推进到了新阶段，其中 1 款获批上市，3 款申报上市，33 款启动临床，12 款申报临床。下文，Insight 将分别摘取本周国内外部分重点项目进展做介绍。境外创新药进展境外部分，本周共有 37 款药物研发阶段推进，包括 2 款获批上市，2 款申报上市，2 款首次启动 III 期临床...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.